One picture is worth a thousand words.
Fred R. Barnard
Tweets of the Day
Well, I never thought I would be debating public policy with a cancer patient on Twitter. I am not unsympathetic with the experience of cancer patients; my maternal grandmother (and godmother) died from the complications of colon cancer when I was 2 years old and my mom was 22. I don't usually publish extended Twitter dialogues but I made some crucial points during the exchange.
Rand Paul is once again proving why he, not Donald Trump, should be POTUS. Torture of suspects is immoral. counterproductive public policy.— Ronald Guillemette (@raguillem) January 27, 2017
"C4L Is Lobbying To Get Ron Paul Appointed To The Federal Reserve Board". Oh, God, YES!— Ronald Guillemette (@raguillem) January 27, 2017
Unlike politics, any scientific theory is subject to evidence and its standard validated measurement. #whysciencematters— Ronald Guillemette (@raguillem) January 27, 2017
Abolish executive orders & make lawmakers fully accountable for the unintended economic consequences of bad regulations. #MyExecutiveOrder— Ronald Guillemette (@raguillem) January 27, 2017
Trump's edict on sanctuary cities is as unconstitutional as Obama's abuses of power. Does GOP believe in federalism? https://t.co/y8yUzTQEhE— Ronald Guillemette (@raguillem) January 27, 2017
Leave it to the maid #HouseholdTVShows— Ronald Guillemette (@raguillem) January 27, 2017
Trump's edict on sanctuary cities is as unconstitutional as Obama's abuses of power. Does GOP believe in federalism? https://t.co/y8yUzTQEhE— Ronald Guillemette (@raguillem) January 27, 2017
Is it too early to talk about impeaching Donald Trump?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 Nobody seriously believes that the public grant system works as intended. Govt spending is risk-averse https://t.co/e9otfOIBI5— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic You don't see the chilling effect of government on innovative research in the private sector, e.g.,delays of drug approval— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic But would that have emerged without government intervention? Absolutely. Companies don't grow on killing their consumers.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic So you're saying government scaled back its preexisting dysfunctional regulations this one time, and you're grateful?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic And tell me--did your cure come from a government-produced drug?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Gee, your drug may have been released EVEN EARLIER during your illness. That's a bad thing?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic The point is,FOR THE GENERAL PATIENTS, they have to wait until the FDA gives its imprimatur. Other patients like you died.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic What use is a drug once the patient passes away unable to take it? The govt gave her a death sentence for her own good.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Government grants aren't distributed by risk-takers. The private sector spends far more. Private science is bigger.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Do you know how many hurdles you have to go through to market a drug? Who wins the race--the sprinter or the hurdler?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic No, there are bureaucratic incentives against innovation. Innovators often think out of the box--not rewarded by govt.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic It's not just groupthink, but government is monopoly. You have people scared of approving a "bad" drug and getting blamed.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Yes, but govt doesn't take the risk. Over 90% of drugs don't make it to market. Who foots the bill for their costs?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic For too many patients, their only lifeline is getting access to new drugs. And while regulators hesitate, real people die.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Again, the government is de facto making a judgment of life and death. The government gets in the way of saving lives.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic If Shkreli made the drug that's made the difference for you, would you really care about purported securities fraud?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Better than a 4-1 kill ratio for drug delay vs. bad drugs. https://t.co/73zVJFaMnZ— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic If your issue is Big Pharma, you should logically be calling for a free market and more market competition.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @mic Government employees or the private sector (including charities, nonprofits, etc.)?— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 @CatoInstitute If you read the article, they were making reference to statistics from countries with less restrictive approvals— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 Not companies like Celgene, right? This isn't funny anymore. I'm getting bored.— Ronald Guillemette (@raguillem) January 27, 2017
@PamCollier2 Most science is privately-funded. You are blinded by your political dogma. Educate yourself. https://t.co/sPEzMN97hp— Ronald Guillemette (@raguillem) January 27, 2017
Image of the Day
Great Examples of Failed US Government-Owned Businesses
End the Public School Monopoly
Political Cartoon
 |
| Courtesy of Jerry Holbert via Townhall |
Musical Interlude: My Favorite Vocalists
Pat Benatar, "You Better Run"
